Walleye Capital’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Walleye Capital’s Portfolio COEPW Stock Details COEPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-109,050	Closed	-$1.64K	–	4933
2024 Q3	$1.64K	Hold	109,050	–	–	﹤0.01%	5108
2024 Q2	$3.27K	Hold	109,050	–	–	﹤0.01%	5372
2024 Q1	$2.78K	Hold	109,050	–	–	﹤0.01%	5228
2023 Q4	$3.38K	Hold	109,050	–	–	﹤0.01%	4698
2023 Q3	$2.46K	Hold	109,050	–	–	﹤0.01%	4695
2023 Q2	$7.82K	Hold	109,050	–	–	﹤0.01%	3951
2023 Q1	$16.1K	Sell	109,050 -58,957	-35%	-$7.61K	﹤0.01%	3447
2022 Q4	$16.8K	Buy	168,007 +59,597	+55%	+$3.98K	﹤0.01%	2686
2022 Q3	$3K	Hold	108,410	–	–	﹤0.01%	3003
2022 Q2	$4K	Buy	108,410 +21,351	+25%	+$1.6K	﹤0.01%	2158
2022 Q1	$7K	Sell	87,059 -100	-0.1%	-$16	﹤0.01%	2153
2021 Q4	$28K	Sell	87,159 -141	-0.2%	-$47	﹤0.01%	1863
2021 Q3	$23	Hold	87,300	–	–	﹤0.01%	1477
2021 Q2	$47	Hold	87,300	–	–	﹤0.01%	1228
2021 Q1	$38	Buy	87,300 +12,000	+16%	+$11.3K	﹤0.01%	1079
2020 Q4	$104	Buy	+75,300	New	+$69.4K	0.01%	813

Other funds holding COEPW

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

SIA

SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return

LCM

Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

HHGC

Hunting Hill Global Capital New York $129M AUM 17.34% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Walleye Capital's COEPW Position: Q4 2024 in Review

Walleye Capital sold out of Coeptis Therapeutics Warrants (COEPW) in Q4 2024, closing a stake of 109,050 shares — an estimated $1.64K sold.

Walleye Capital first reported a position in COEPW in Q4 2020 and held it in 16 quarters. The position peaked at $28K in Q4 2021. 13 funds tracked by Wall St. Rank hold COEPW as of Q4 2024.

Walleye Capital reported no remaining Coeptis Therapeutics Warrants position as of Q4 2024 after selling out during the quarter.
Walleye Capital sold 109,050 Coeptis Therapeutics Warrants shares in Q4 2024, an estimated $1.64K.
Walleye Capital first reported a position in Coeptis Therapeutics Warrants in Q4 2020 and held it in 16 quarters.
Walleye Capital's Coeptis Therapeutics Warrants position peaked at $28K in Q4 2021.
13 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q4 2024.

Based on Walleye Capital's 13F filing for Q4 2024, filed 13 Feb 2025.